We demonstrate here that RNA levels of 25-hydroxyvitamin D 3 -24-hydroxylase (24-(OH)ase), a key catabolic enzyme for 1,25-dihydroxyvitamin D 3 , are increased by a highly selective retinoid X receptor (RXR) ligand, LG100268, in mice within hours. Correspondingly, upon LG100268 treatment, kidney 24-(OH)ase enzymatic activity increases 5-10-fold. The endogenous retinoid hormones, all-trans-retinoic acid and 9-cis-retinoic acid, and the synthetic retinoic acid receptor-selective compound, TTNPB, also stimulate 24-(OH)ase. Additionally, we show that LG100268 stimulates transcription of a luciferase reporter plasmid driven by 24-(OH)ase promoter sequences in the presence of RXR in CV-1 cell cotransactivation assays. This first demonstration of a gene that is regulated in the intact animal through an RXR-mediated pathway confirms earlier hypotheses that RXR is a bona fide hormone receptor. Regulation of a key gene in the vitamin D signaling pathway by a retinoid transducer may provide a molecular basis for some of the documented biological effects of vitamin A on bone and vitamin D metabolism.
Retinoic acid receptors (RARs)1 have been shown to act as hormone receptors by virtue of the fact that they bind all-transretinoic acid (tRA) with high affinity and activate target genes in the presence of tRA in cell-based cotransactivation assays and in vivo (reviewed in Ref. 1). Retinoid X receptors (RXRs) are also thought to act as hormone receptors (reviewed in Ref. 1) since they bind 9-cis-retinoic acid (9cRA) with high affinity (2, 3) and have been shown to stimulate transcription from distinct elements known as RXR-responsive elements in promoter sequences of the apolipoprotein A1 (apoA1) and cellular retinol-binding protein II (CRBPII) genes in cell-based cotransactivation assays in response to 9cRA (2, 3), tRA (4, 5), or RXR-selective ligands (6, 7). However, these genes have not been shown to be regulated by retinoids in vivo. While another gene product (growth hormone) has been shown to increase in cultured cells treated with RXR-and RAR-selective ligands (8), there are currently no known biological target genes of RXR in the intact animal.RXRs are thought to form homodimers upon interaction with ligand (1) to activate putative RXR-selective genes, such as CRBPII and apoA1, through RXR-responsive elements in the promoters of those genes (2-7). RXR is also known to participate in heterodimers with a number of other intracellular receptors, including the vitamin D receptor (VDR), RAR, or thyroid hormone receptor to activate a variety of target genes, which are stimulated by 1,25-dihydroxyvitamin D 3 (1,25-(OH) 2 D 3 ), tRA, or thyroid hormone, respectively (1). RXR is thought to act as a silent partner in these interactions, although the effects of liganding of RXR under these circumstances have not been thoroughly explored. Additionally, recent studies describe instances of stimulation of gene transcription by hormone-occupied RXR interacting with a supposedly unoccupied orphan receptor (9, 10).To study the consequen...